KENLIFABI

Swiss trademark · 766633 · Word mark · In force

Register entry

Registration number
766633
Application number
11036/2021
Status
In force
Type
Word mark
Filed
Jul 13, 2021
Registered
Jul 14, 2021
Published
Jul 14, 2021
Protected until
Jul 13, 2031
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Produkte zur Anwendung beim Menschen zur Behandlung von Morbus Fabry und Symptomen und Folgeerscheinungen von Morbus Fabry sowie zur Behandlung von Glykolipidspeicherkrankheiten.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 7, 2026

    Pledge entered

    Pledgee
    BioPharma Credit PLC, 19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, United Kingdom

    Published in Swissreg on 07.07.2026

  2. Jul 14, 2021

    Registered

    Published in Swissreg on 14.07.2021

Parties

Holder

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Agent

Keller Schneider Patent- und Markenanwälte AG

Beethovenstrasse 49 Postfach, 8027 Zürich

Pledgee

BioPharma Credit PLC

19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, GB

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.